ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc.

NEW YORK, Feb. 21, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by bluebird bio, Inc. (NASDAQ: BLUE) and its board of directors concerning the proposed acquisition of the company by Carlyle (NASDAQ: CG) and SK Capital Partners, LP. Stockholders will receive $3.00 and a contingent value right of $6.84 for each share of bluebird bio stock that they hold. The transaction is expected to close in the first half of 2025.